liver cancer造句61. Objective The aim of this study was to explore the surgical treatment and effect for spontaneous rupture and hemorrhoea of liver cancer.
62. It is reported that the aflatoxin B 1 ( AFB 1 ) is a carcinogen that inducing the liver cancer.
63. Objective : To explore the characteristics of the sublingual venae in patients with primary liver cancer ( PLC ) .
64. Objective To study the epidemiologic characteristics of primary liver cancer ( PLC ) .
65. Methods: albumin nanoparticles were injected into hepatic artery of rats with transplanted liver cancer.
66. Conclusion The occult infection of HBV may be an important cause of cryptogenic cirrhosis and liver cancer.
67. Objective To investigate the efficacy of implantable infusion pump in the treatment of un resectable liver cancer.
68. Liver cancer. People with cirrhosis are at higher risk for liver cancer.
69. Mariana washed for a living after her husband died of liver cancer.
70. Liver cancer was induced by Low close aflatoxin B _ 1 ( AFB _ 1 ) and inhibited by Polystictus Versicolor Polysaccharide ( PVP ) in rats.
71. Conclusion Detecting the content of liverish patients GMP-140 can be a guideline of sthenic fibrinolysis in liverish patients especially liver cancer patients and to evaluate the prognosis.
72. This article reviews some progresses in interventional therapy of liver cancer.
73. The use of thoria (thorium dioxide) as an agent was rapidly stopped as thorium causes liver cancer.
74. Objective To explore the inhibitory effects of extracts from Trapa manshurica Fler. on liver cancer cells in vivo and in vitro.
75. Objective To study effects of low energy laser irradiation unite Solanum nigrum polysaccharides on immune cells in liver cancer loaded mouse.
76. Conclusion:Postoperative after-loading radiotherapy with gemcitabine is an effective way for the treatment of primary liver cancer.
77. Objective To study the antitumor effect of novobiocin( NOVO ) on patients primary liver cancer cells, and the modulation of NOVO on some clinical antitumor drugs.
78. The course of primary liver cancer was unrelated to the incidence of subphrenic infection.
79. Results:The average absorbed dose of the hepatic tissue when targeted therapy liver cancer by nanometer-iron nuclide was estimated in theory.
80. In liver cancer tissues, the HCV core antigen cytoplasmic positive cells were focally distributed and whereas the nuclear positive cells were diffusely distributed.
81. Objective To state operative details of lip-shaped hepatectomy (LSH) and evaluate its advantage in treatment of primary liver cancer (PLC).
82. Characteristics of sublingual venae in primary liver cancer patients in different clinical stages.
83. Friotherapy, using liquid N 2 as cryogen, may be applied for all stages of liver cancer, which mechanism is tissue destruction due tol ow temperature. directly and improvement of immunity.
84. The results showed that the serum SA measurement may be useful for the detection of liver cancer and for the differential diagnosis of the primary liver cancers and the nonmalignant liver diseases.
85. It is confirmed that the dysplastic nodule of liver cirrhosis is an important precancer to liver cancer.
86. Objective To study the clinicopathological changes and post - operative course following transcatheter hepatic arterial chemo- embolization (TACE) in primary liver cancer (PLC).
87. Objective To explore the effecting factors of liver cancer recurrence after hepatectomy.